KELLY JARED (Chief Executive Officer) purchased 4.6% of their position (5.05K shares) of ONCOLYTICS BIOTECH INC on the open market
Open‑market purchase worth $4.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/13/2026ACC: 0001493152-26-009982
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+5.05K
Net shares
Net buyer
$4.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.05K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+5.05K
Price / share
$0.96
Trade value
$4.85K
% of position
4.6%
3/12/2026
109K→114.05K
Total
Net shares
+5.05K
Net value
$4.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/12/2026 | P · Purchase | +5.05K | $0.96 | $4.85K | 4.6% | 109K | 114.05K |
| Total | +5.05K | $4.85K | ||||||
Derivative Transactions0
No derivative transactions reported